The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors
Abstract Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive sarcoma that may be seen in patients with neurofibromatosis type 1 (NF1) or occur sporadically. While surgery is the primary treatment for localized MPNST with a 61.9% overall survival rate, metastatic disease is often f...
Saved in:
| Main Authors: | Imad Soukar, Robert J. Fisher, Sanjana Bhagavatula, Marianne Collard, Philip A. Cole, Rhoda M. Alani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-94517-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CoREST3 exhibits isoform specific expression in Alzheimer’s disease and regulation of HDAC2
by: Simon Maksour, et al.
Published: (2025-08-01) -
Genomic profiling and pathological assessment of malignant peripheral nerve sheath tumors
by: Qian Cui, et al.
Published: (2025-05-01) -
A Metastatic Malignant Peripheral Nerve Sheath Tumor with Its Imaging Features
by: Saloni Rajkotia, et al.
Published: (2025-01-01) -
Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor
by: Xiao‐Xiao Li, et al.
Published: (2018-09-01) -
Galectin-1 Inhibition as a Strategy for Malignant Peripheral Nerve Sheath Tumor Treatment
by: Hsiao-Chi Wang, et al.
Published: (2025-03-01)